Table 2

Aqueous endocannabinoid levels

2-AGAEAOEAPEASum
AllMean0.070.110.160.921.13
SEM0.010.010.020.080.11
FemaleMean0.060.130.181.111.65
SEM0.020.020.020.110.18
MaleMean0.100.090.130.631.00
SEM0.020.020.020.090.15
Without diabetesMean0.050.130.170.961.29
SEM0.010.020.021.100.23
With diabetesMean0.080.070.140.851.35
SEM0.020.020.030.110.23
Women without diabetesMean0.050.200.291.222.04
SEM0.020.030.040.140.28
Women with diabetesMean0.080.070.140.831.34
SEM0.030.020.030.140.30
Men without diabetesMean0.040.090.130.520.85
SEM0.010.020.020.100.14
Men with diabetesMean0.120.130.210.891.35
SEM0.050.060.080.200.35
No ocular comorbidityMean0.150.160.220.941.44
SEM0.030.030.030.110.17
Ocular comorbidityMean0.340.350.431.362.49
SEM0.140.110.160.340.73
  • The table reports the mean concentration (nM) and SEM of specific endocannabinoids found in the aqueous humour of patients with cataract. Patients are grouped by gender, diabetic status and presence of ocular comorbidity.

  • AEA, anandamide; 2-AG, 2-arachidonoylglycerol; OEA, oleoylethanolamine; PEA, palmitoylethanolamine.